These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 18243708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL, Vieira TC, Gomes MP, Rangel LP, Scapin SM, Cordeiro Y.
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Generation of genuine prion infectivity by serial PMCA.
    Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, Kretzschmar HA.
    Vet Microbiol; 2007 Aug 31; 123(4):346-57. PubMed ID: 17493773
    [Abstract] [Full Text] [Related]

  • 5. The highways and byways of prion protein trafficking.
    Campana V, Sarnataro D, Zurzolo C.
    Trends Cell Biol; 2005 Feb 31; 15(2):102-11. PubMed ID: 15695097
    [Abstract] [Full Text] [Related]

  • 6. Structural insights into the interaction between prion protein and nucleic acid.
    Lima LM, Cordeiro Y, Tinoco LW, Marques AF, Oliveira CL, Sampath S, Kodali R, Choi G, Foguel D, Torriani I, Caughey B, Silva JL.
    Biochemistry; 2006 Aug 01; 45(30):9180-7. PubMed ID: 16866364
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK, Jones EM, Apetri AC.
    Acc Chem Res; 2006 Sep 01; 39(9):654-62. PubMed ID: 16981682
    [Abstract] [Full Text] [Related]

  • 10. Modeling and analysis of prion dynamics in the presence of a chaperone.
    Kumar R, Murali P.
    Math Biosci; 2008 May 01; 213(1):50-5. PubMed ID: 18362035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infectious nucleic acids in prion disease: halfway there.
    Radulescu RT, Brenig B.
    Trends Biochem Sci; 2009 Jan 01; 34(1):4-5; author reply 5-6. PubMed ID: 18996016
    [No Abstract] [Full Text] [Related]

  • 14. The role of RNA in mammalian prion protein conversion.
    Gomes MP, Vieira TC, Cordeiro Y, Silva JL.
    Wiley Interdiscip Rev RNA; 2012 Jan 01; 3(3):415-28. PubMed ID: 22095764
    [Abstract] [Full Text] [Related]

  • 15. [Prion protein and copper: a mysterious relationship].
    Rachidi W, Riondel J, McMahon HM, Favier A.
    Pathol Biol (Paris); 2005 May 01; 53(4):244-50. PubMed ID: 15850959
    [Abstract] [Full Text] [Related]

  • 16. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
    Wang W, Chen R, Luo K, Wu D, Huang L, Huang T, Xiao G.
    J Cell Biochem; 2010 Oct 01; 111(2):343-9. PubMed ID: 20506117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.